169 related articles for article (PubMed ID: 35371954)
21. The value of quantitative CT texture analysis in differentiation of angiomyolipoma without visible fat from clear cell renal cell carcinoma on four-phase contrast-enhanced CT images.
You MW; Kim N; Choi HJ
Clin Radiol; 2019 Jul; 74(7):547-554. PubMed ID: 31010583
[TBL] [Abstract][Full Text] [Related]
22. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
Qu JY; Jiang H; Song XH; Wu JK; Ma H
Diagn Interv Radiol; 2023 Mar; 29(2):205-211. PubMed ID: 36960636
[TBL] [Abstract][Full Text] [Related]
23. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
[TBL] [Abstract][Full Text] [Related]
25. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
26. Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.
Brennan K; Metzner TJ; Kao CS; Massie CE; Stewart GD; Haile RW; Brooks JD; Hitchins MP; Leppert JT; Gevaert O
JCO Precis Oncol; 2020; 4():. PubMed ID: 33015531
[TBL] [Abstract][Full Text] [Related]
27. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
28. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography.
Wang D; Huang X; Bai L; Zhang X; Wei J; Zhou J
Acta Radiol; 2020 Nov; 61(11):1562-1569. PubMed ID: 32088966
[TBL] [Abstract][Full Text] [Related]
29. Can Quantitative CT Texture Analysis be Used to Differentiate Fat-poor Renal Angiomyolipoma from Renal Cell Carcinoma on Unenhanced CT Images?
Hodgdon T; McInnes MD; Schieda N; Flood TA; Lamb L; Thornhill RE
Radiology; 2015 Sep; 276(3):787-96. PubMed ID: 25906183
[TBL] [Abstract][Full Text] [Related]
30. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between renal oncocytomas and chromophobe renal cell carcinomas using dynamic contrast-enhanced computed tomography.
Guo K; Ren S; Cao Y; Zhang H; Zhang Y; Gu X; Wang Z
Abdom Radiol (NY); 2021 Jul; 46(7):3309-3316. PubMed ID: 33710383
[TBL] [Abstract][Full Text] [Related]
32. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
[TBL] [Abstract][Full Text] [Related]
33. Fat poor angiomyolipoma differentiation from renal cell carcinoma at 320-slice dynamic volume CT perfusion.
Chen C; Kang Q; Xu B; Shi Z; Guo H; Wei Q; Lu Y; Wu X
Abdom Radiol (NY); 2018 May; 43(5):1223-1230. PubMed ID: 28828638
[TBL] [Abstract][Full Text] [Related]
34. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
36. Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma.
Chen F; Gulati M; Hwang D; Cen S; Yap F; Ugwueze C; Varghese B; Desai M; Aron M; Gill I; Duddalwar V
Abdom Radiol (NY); 2017 Feb; 42(2):552-560. PubMed ID: 27595574
[TBL] [Abstract][Full Text] [Related]
37. Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma.
Jeong CJ; Park BK; Park JJ; Kim CK
AJR Am J Roentgenol; 2016 Feb; 206(2):340-7. PubMed ID: 26797361
[TBL] [Abstract][Full Text] [Related]
38. Multi-Phase Multiple Detector Computed Tomography (MDCT) Enhancement Patterns and Morphological Features of Chromophobe Renal Cell Carcinoma: An Analysis of 67 Cases.
Luo M; Zhu Y; Chen S; Huang Q; Zhang W; Ma M; Wei Y
Med Sci Monit; 2021 Apr; 27():e929287. PubMed ID: 33907175
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).
Schieda N; Al-Subhi M; Flood TA; El-Khodary M; McInnes MD
Eur Radiol; 2014 Nov; 24(11):2787-94. PubMed ID: 25027841
[TBL] [Abstract][Full Text] [Related]
40. Early dark cortical band sign on CT for differentiating clear cell renal cell carcinoma from fat poor angiomyolipoma and detecting peritumoral pseudocapsule.
Ogawa Y; Morita S; Takagi T; Yoshida K; Tanabe K; Nagashima Y; Nishina Y; Sakai S
Eur Radiol; 2021 Aug; 31(8):5990-5997. PubMed ID: 33559699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
